Legler K - Search Results

1

Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.

Hamester F, Stürken C, Saygi C, Qi M, Legler K, Gorzelanny C, Robador JR, Schmalfeldt B, Laakmann E, Müller V, Witzel I, Oliveira-Ferrer L. Hamester F, et al. Among authors: legler k. Int J Mol Sci. 2022 Feb 8;23(3):1900. doi: 10.3390/ijms23031900. Int J Mol Sci. 2022. PMID: 35163822 Free PMC article.

2

Role of protein glycosylation in cancer metastasis.

Oliveira-Ferrer L, Legler K, Milde-Langosch K. Oliveira-Ferrer L, et al. Among authors: legler k. Semin Cancer Biol. 2017 Jun;44:141-152. doi: 10.1016/j.semcancer.2017.03.002. Epub 2017 Mar 16. Semin Cancer Biol. 2017. PMID: 28315783 Review.

3

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients.

Kuerti S, Oliveira-Ferrer L, Milde-Langosch K, Schmalfeldt B, Legler K, Woelber L, Prieske K, Mahner S, Trillsch F. Kuerti S, et al. Among authors: legler k. Oncotarget. 2017 Jun 27;8(26):43218-43227. doi: 10.18632/oncotarget.17978. Oncotarget. 2017. PMID: 28591727 Free PMC article.

4

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer.

Legler K, Rosprim R, Karius T, Eylmann K, Rossberg M, Wirtz RM, Müller V, Witzel I, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L. Legler K, et al. Br J Cancer. 2018 Mar 20;118(6):847-856. doi: 10.1038/bjc.2017.472. Epub 2018 Jan 30. Br J Cancer. 2018. PMID: 29381688 Free PMC article.

5

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.

Oliveira-Ferrer L, Goswami R, Galatenko V, Ding Y, Eylmann K, Legler K, Kürti S, Schmalfeldt B, Milde-Langosch K. Oliveira-Ferrer L, et al. Among authors: legler k. Dis Markers. 2018 Jun 28;2018:6714287. doi: 10.1155/2018/6714287. eCollection 2018. Dis Markers. 2018. PMID: 30050594 Free PMC article.

6

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.

Hamester F, Legler K, Wichert B, Kelle N, Eylmann K, Rossberg M, Ding Y, Kürti S, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L. Hamester F, et al. Among authors: legler k. Br J Cancer. 2019 Nov;121(11):944-953. doi: 10.1038/s41416-019-0607-2. Epub 2019 Oct 29. Br J Cancer. 2019. PMID: 31659304 Free PMC article.

7

Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.

Ding Y, Labitzky V, Legler K, Qi M, Schumacher U, Schmalfeldt B, Stürken C, Oliveira-Ferrer L. Ding Y, et al. Among authors: legler k. Mol Oncol. 2021 Dec;15(12):3578-3595. doi: 10.1002/1878-0261.13028. Epub 2021 Jun 18. Mol Oncol. 2021. PMID: 34060699 Free PMC article.

8

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients.

Ding Y, Oliveira-Ferrer L, Vettorazzi E, Legler K, Milde-Langosch K, Woelber L, Jaeger A, Prieske K, Mueller V, Schmalfeldt B, Kuerti S. Ding Y, et al. Among authors: legler k. PLoS One. 2022 Jun 10;17(6):e0269680. doi: 10.1371/journal.pone.0269680. eCollection 2022. PLoS One. 2022. PMID: 35687576 Free PMC article.

9

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer.

Hamester F, Stürken C, Legler K, Eylmann K, Möller K, Roßberg M, Gorzelanny C, Bauer AT, Windhorst S, Schmalfeldt B, Laakmann E, Müller V, Witzel I, Oliveira-Ferrer L. Hamester F, et al. Among authors: legler k. Cells. 2022 Oct 18;11(20):3275. doi: 10.3390/cells11203275. Cells. 2022. PMID: 36291142 Free PMC article.

10

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients.

Reimer F, Bryan S, Legler K, Karn T, Eppenberger-Castori S, Matschke J, Pereira-Veiga T, Wikman H, Witzel I, Müller V, Schmalfeldt B, Milde-Langosch K, Schumacher U, Stürken C, Oliveira-Ferrer L. Reimer F, et al. Among authors: legler k. Cancer Cell Int. 2023 Mar 16;23(1):47. doi: 10.1186/s12935-023-02896-9. Cancer Cell Int. 2023. PMID: 36927383 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page